Insider Transactions in Q1 2023 at Hca Healthcare, Inc. (HCA)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2023
|
Bill B Rutherford CFO and EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
64,000
+19.6%
|
$4,416,000
$69.27 P/Share
|
|
Feb 01
2023
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
586
-4.77%
|
$149,430
$255.07 P/Share
|
|
Feb 01
2023
|
Christopher F. Wyatt SVP & Controller |
SELL
Open market or private sale
|
Direct |
4,900
-13.14%
|
$1,239,700
$253.3 P/Share
|
|
Feb 01
2023
|
P. Martin Paslick SVP and CIO |
SELL
Open market or private sale
|
Indirect |
1,000
-25.0%
|
$256,000
$256.95 P/Share
|
|
Feb 01
2023
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-16.11%
|
$1,028,000
$257.11 P/Share
|
|
Feb 01
2023
|
Jon M Foster EVP and COO |
SELL
Open market or private sale
|
Direct |
16,424
-60.02%
|
$4,122,424
$251.98 P/Share
|
|
Jan 31
2023
|
Kathleen M Whalen SVP & Chief Ethics Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+9.24%
|
$86,250
$69.58 P/Share
|
|
Jan 31
2023
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Bona fide gift
|
Direct |
341
-3.0%
|
-
|
|
Jan 31
2023
|
Christopher F. Wyatt SVP & Controller |
SELL
Bona fide gift
|
Direct |
379
-1.01%
|
-
|
|
Jan 30
2023
|
Christopher F. Wyatt SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
6,513
-14.74%
|
$1,647,789
$253.3 P/Share
|
|
Jan 30
2023
|
Christopher F. Wyatt SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+21.36%
|
$972,000
$81.96 P/Share
|
|
Jan 30
2023
|
Timothy M Mc Manus Group President |
SELL
Open market or private sale
|
Direct |
7,900
-18.17%
|
$2,006,600
$254.33 P/Share
|
|
Jan 30
2023
|
Jon M Foster EVP and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
19,531
-41.65%
|
$4,941,343
$253.3 P/Share
|
|
Jan 30
2023
|
Jon M Foster EVP and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
35,955
+30.52%
|
$2,480,895
$69.27 P/Share
|
|
Jan 30
2023
|
Sammie S Mosier SVP & Chief Nurse Executive |
SELL
Payment of exercise price or tax liability
|
Direct |
74
-1.07%
|
$18,722
$253.3 P/Share
|
|
Jan 30
2023
|
Sammie S Mosier SVP & Chief Nurse Executive |
BUY
Exercise of conversion of derivative security
|
Direct |
273
+3.8%
|
-
|
|
Jan 30
2023
|
Richard A Hammett Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
146
-1.67%
|
$36,938
$253.3 P/Share
|
|
Jan 30
2023
|
Richard A Hammett Group President |
BUY
Exercise of conversion of derivative security
|
Direct |
598
+6.4%
|
-
|
|
Jan 29
2023
|
Sammie S Mosier SVP & Chief Nurse Executive |
SELL
Payment of exercise price or tax liability
|
Direct |
96
-1.42%
|
$24,384
$254.77 P/Share
|
|
Jan 29
2023
|
Sammie S Mosier SVP & Chief Nurse Executive |
BUY
Exercise of conversion of derivative security
|
Direct |
322
+4.56%
|
-
|
|
Jan 29
2023
|
Richard A Hammett Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
165
-1.99%
|
$41,910
$254.77 P/Share
|
|
Jan 29
2023
|
Richard A Hammett Group President |
BUY
Exercise of conversion of derivative security
|
Direct |
600
+6.73%
|
-
|
|
Jan 28
2023
|
Michael R Mc Alevey EVP - Chief Legal & Admin Off |
SELL
Payment of exercise price or tax liability
|
Direct |
489
-16.03%
|
$124,206
$254.77 P/Share
|
|
Jan 28
2023
|
Michael R Mc Alevey EVP - Chief Legal & Admin Off |
BUY
Exercise of conversion of derivative security
|
Direct |
1,940
+38.88%
|
-
|
|
Jan 23
2023
|
P. Martin Paslick SVP and CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,966
-11.81%
|
$780,058
$263.81 P/Share
|
|
Jan 23
2023
|
P. Martin Paslick SVP and CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+19.29%
|
$486,000
$81.96 P/Share
|